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Prediction and improvement of oocyte competence are two critical issues in assisted reproductive technology to improve infertility
therapy. The lack of reliable and objective predictors of oocyte developmental competence for oocyte/embryo selection during
in vitro fertilization hampers the effectiveness of this technology. Likewise, the low pregnancy rate resulting from in vitro matu-
ration of human oocytes represents a major obstacle for its clinical application. Oocyte competence is progressively acquired
during follicular development, and the oocyte plays a dominant role in regulating granulosa cell functions and maintaining the
microenvironment appropriate for the development of its competence. Hence, granulosa cell functions are reﬂective of oocyte
competence, and molecular markers of granulosa cells are potentially reliable predictors of oocyte quality. With the advent of
the functional genomics era, the transcriptome of granulosa cells has been extensively characterized. Experimental data support-
ing granulosa cell markers as predictors of oocyte competence are now emerging in both animal models and humans. Future
efforts should focus on integrating granulosa cell genetic markers as parameters for oocyte/embryo selection. Moreover, novel
in vitro evidence highlights the effectiveness of exogenous oocyte-secreted factors in promoting oocyte developmental competence
in animal models. The challenge in evaluating the effect of oocyte-secreted factors on oocyte quality in a clinical setting is to stan-
dardize the various preparations of these recombinant proteins and decipher their complex interactions/cooperativity within the
germline-somatic cell regulatory loop.
Introduction
Two key technical issues to be resolved in assisted reproductive tech-
nology (ART) are the lack of objective and reliable predictors of
oocyte developmental competence and the low successful rate of in
vitro maturation (IVM). Oocyte competence is deﬁned as the intrinsic
ability of oocytes to undergo meiotic maturation, fertilization,
embryonic development and successful pregnancy. Hence, utilization
of the most competent oocytes during in vitro fertilization (IVF) is
crucial to ensure the derivation of high-qualityembryos and successful
pregnancy. The morphological parameters of the cytoplasm, polar
body and cumulus cells are routinely used for oocyte selection
(Coticchio et al., 2004; Wang and Sun, 2007). However, the morpho-
logical criteria for grading and screening of oocytes are subjective and
controversial (Serhal et al., 1997; Balaban et al., 1998). Thus, deﬁning
objective and noninvasive molecular markers predictive of oocyte
competence is of critical importance. Moreover, since single-embryo
transfer (SET), which has the key advantage of preventing multiple
pregnancies (Gerris, 2005; Karlstrom and Bergh, 2007; Khalaf
et al., 2008), will tend to be a norm in the future (Nygren, 2007), it
is urgent to develop such a reliable diagnostic approach to identify
the best quality embryo among those available for transfer. Notably,
acquisition of oocyte competence is closely associated with normal
follicular development, whereby the oocyte plays an active role in reg-
ulating the functions of surrounding somatic cells (i.e. cumulus cells
adjacent to the oocyte and mural granulosa cells lining the follicle
wall) (Eppig et al., 1997, 2002; Eppig, 2001; Matzuk et al., 2002).
Therefore, identiﬁcation of key molecules and signaling pathways
within the oocyte–cumulus cell regulatory loop will be instrumental
in gaining deep insights into the intricate mechanisms underlying
the development of oocyte competence and uncovering novel regula-
tors and reliable molecular predictors of oocyte quality. These efforts
will ultimately lead to improved efﬁciency and health outcomes (i.e.
reduced prematurity/perinatal mortality rate and maternal and pedi-
atric complications) of ART.
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story conveys new messages
Folliculogenesis is coordinately regulated by both endocrine and
intraovarian factors; the fundamental roles of gonadotrophins and
gonadotrophin-mediated signaling in multiple reproductive events
including cumulus expansion and acquisition of oocyte competence
have been well characterized and documented (Kumar et al., 1997;
Thomas et al., 2003; Ma et al., 2004; Park et al., 2004; Conti et al.,
2006; Sirard et al., 2007). This article mainly focuses on the
recent advances in understanding the contribution of intraovarian
factors, especially oocyte-produced factors, to oocyte developmental
competence.
It is known that bidirectional interactions between the oocytes and
surrounding somatic cells through gap junctions and paracrine signal-
ing are pivotal in maintaining the growth and development of both cell
types during folliculogenesis (Eppig, 1991, 2001; Eppig et al., 1997,
2002; Matzuk et al., 2002). Instead of being a passive recipient of
nutritional support and regulatory signals from its companion granu-
losa cells, the oocyte plays an active role throughout folliculogenesis
via secretion of paracrine factors that maintain an appropriate micro-
environment for the acquisition of its developmental competence
(Dong et al., 1996; Eppig et al., 1997, 2002; Eppig, 2001; Gilchrist
et al., 2004). Importantly, oocytes specify the phenotype of adjacent
cumulus cells, which is essential for oocyte development and
cumulus cell function (Eppig et al., 1997; Li et al., 2000; Diaz
et al., 2007). Furthermore, the SMAD2/3 pathway, one of the path-
ways downstream of transforming growth factor b (TGFb) superfam-
ily ligands in mammals, mediates oocyte signals that contribute to the
speciﬁcation of mouse cumulus cell lineage and cumulus expansion
(Diaz et al., 2007; Dragovic et al., 2007). Studies on Smad2/3 con-
ditional knockout mice in our group indicate that ovarian SMAD2
and SMAD3 are indispensable for normal cumulus expansion in
mouse (Li et al., 2008). The requirement of SMAD2/3 signaling in
the initiation of cumulus expansion and induction of cumulus
expansion-related genes (Diaz et al., 2007; Dragovic et al., 2007) as
well as the defective cumulus phenotype manifested in Smad4 con-
ditional knockout model (Pangas et al., 2006) reemphasize the funda-
mental role of oocyte-secreted factors of the TGFb superfamily in
promoting cumulus cell function. Although the nature of the
cumulus expansion-enabling factors is still unclear, it is highly poss-
ible that growth differentiation factor 9 (GDF9) and other oocyte-
secreted factors are the candidates [e.g. bone morphogenetic protein
15 (BMP15)]. GDF9 can signal through SMAD2/3 to regulate granu-
losa cell function (Kaivo-Oja et al., 2003; Gilchrist et al., 2006).
GDF9 induces the expression of expansion-related transcripts [pen-
traxin 3 (Ptx3), hyaluronan synthase 2 (Has2), tumor necrosis factor
alpha-induced protein 6 (Tnfaip6) and prostaglandin-endoperoxide
synthase 2 (Ptgs2)] in mouse granulosa cells in vitro (Elvin et al.,
1999a; Varani et al., 2002). Another attractive candidate is BMP15,
which can also regulate the function of murine granulosa cells
(Otsuka et al., 2000, 2001; Otsuka and Shimasaki, 2002). Cumulus
expansion and subsequent ovulation are the result of a coordinated
bidirectional communication between oocytes and their companion
somatic cells (Russell and Robker, 2007). Thus, the granulosa cell
pathways are regulated by the oocyte, and the functional properties
of the granulosa cells, especially cumulus cells, are reﬂective of
oocyte quality and the integrity of signaling machinery in the granu-
losa cell compartment. On the basis of this concept, gene expression
proﬁling of granulosa cells may indirectly provide novel and reliable
parameters to assess oocyte competence.
The transcriptional activity of the oocyte genome and the matu-
ration of oocytes are modulated through the dialog between oocytes
and somatic cells during follicular development (Eppig, 1991; Goud
et al., 1998; De La Fuente and Eppig, 2001; Luciano et al., 2005).
The oocytes are supported and nurtured by the closely associated
somatic cells in ovarian follicles, and oocyte growth, meiotic resump-
tion and function are regulated by granulosa cells (Eppig, 1991). For
example, it has been well established that granulosa cell-secreted
KIT ligand (KITL) can bind to its receptor, KIT, which is localized
on the oocyte surface, to stimulate oocyte growth (Packer et al.,
1994). Indeed, KITL is regulated by oocyte-secreted factors (Elvin
et al., 1999b; Joyce et al., 2000; Otsuka and Shimasaki, 2002), and
oocytes from Gdf9 null mice have increased growth rate owing to
the loss of inhibitory effects of GDF9 on Kitl expression (Carabatsos
et al., 1998; Elvin et al., 1999b). A recent study from the Gilchrist
group (Hussein et al., 2005) demonstrated that oocyte-secreted
factors, especially BMP15 and BMP6, protect the cumulus cells
from undergoing apoptosis by establishing a morphogenic paracrine
gradient of BMPs. Undoubtedly, the oocyte will beneﬁt from the
microenvironment where cumulus cells can appropriately maintain
their viability. These results provide additional compelling evidence
that an oocyte creates a favorable microenvironment by utilization
of its own surrounding somatic cells (Hussein et al., 2005). An inter-
esting question is thereby posed: can oocyte-secreted factors be
applied in vitro to enhance oocyte quality (Hussein et al., 2006;
Gilchrist and Thompson, 2007; Yeo et al., 2008)? The following sec-
tions will brieﬂy review recent progress in this ﬁeld, with a focus on
the potential of cumulus genes and oocyte-secreted factors as the
respective predictors and regulators of oocyte competence.
Can granulosa cell-expressed markers become
molecular predictors of oocyte competence?
Cumulus/mural granulosa cells are typically discarded during IVF and
intracytoplasmic sperm injection. These cells are easily accessible and
plentiful, which makes them an ideal material to utilize for the poten-
tial assessment of oocyte quality and embryo development potential.
With the increasing desire to implement more objective and reliable
criteria for oocyte/embryo selection, a signiﬁcant amount of research
has been recently conducted using both animal models and clinical
patients to evaluate the granulosa cell gene signature(s) as molecular
predictors of oocyte competence (McKenzie et al., 2004; Zhang et al.,
2005; Cillo et al., 2007; Feuerstein et al., 2007; Assidi et al., 2008;
Bettegowda et al., 2008; Hamel et al., 2008). Oocyte gene expression
proﬁles have also been investigated in correlation with oocyte compe-
tence (Patel et al., 2007; Hamatani et al., 2008), which is beyond the
focus of this review.
With the advent of the functional genomics era, it has become poss-
ible to identify the transcriptome of granulosa cells using high
throughput technology such as microarray. Evidence supporting gran-
ulosa cell gene markers as predictors of oocyte competence is now
emerging. By using suppressive subtractive cDNA hybridization and
microarray technologies, the Sirard group (Assidi et al., 2008) identi-
ﬁed several potential cumulus cell markers of bovine oocyte compe-
tence including several GDF9 target genes [i.e. HAS2, TNFAIP6,
PTGS2 and gremlin 1 (GREM1)] (Elvin et al., 1999a; Varani et al.,
2002; Pangas et al., 2004). Other candidates identiﬁed are inhibin
bA( INHBA), epidermal growth factor receptor (EGFR), betacellulin
(BTC) and CD44 molecule (CD44) (Assidi et al., 2008). Another
recent study using a bovine ‘poor oocyte competence’ model (prepu-
bertal calf model) and microarray analysis found that the transcript
abundance of genes encoding the cathepsin family of cysteine protein-
ases (CTSB, CTSS and CTSZ) is negatively associated with bovine
oocyte competence (Bettegowda et al., 2008). The potential role of
these genes in apoptosis has been proposed by the authors as treatment
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inhibitor during IVM can reduce apoptotic cumulus cells and
enhance the embryonic development potential of the oocytes (Bette-
gowda et al., 2008).
In search of potential human granulosa cell markers to complement
the morphological criteria toward oocyte/embryo selection, our group
found that the quality of human oocytes is correlated with transcript
abundance for speciﬁc GDF9 targets (i.e. HAS2, PTGS2 and GREM1)
inthecumuluscellcompartment(McKenzieetal.,2004).Asubsequent
study supported that HAS2 and GREM1 are candidate cumulus markers
predictive of oocyte competence (Cillo et al., 2007). However, there
is some controversy regarding the association of cumulus PTX3
abundance with oocyte quality (McKenzie et al., 2004; Zhang et al.,
2005; Cillo et al., 2007). Recently, Feuerstein et al. (2007) reported
that a number of genes including PTGS2, steroidogenic acute protein
(STAR), amphiregulin (AREG), stearoyl-co-enzyme A desaturase 1
a n d5( SCD1 and SCD5) are associated with oocyte nuclear maturation
and their transcript levels are elevated after meiosis resumption. Inter-
estingly, lower cumulus mRNA abundance of the aforementioned
genes as well as connexin 43 (CX43) is present in MII oocytes that
develop to blastocysts (Feuerstein et al., 2007).
Microarray technology is now being applied to deﬁne the gene
expression proﬁles of human ovarian somatic cells in correlation
with oocyte developmental competence (Hamel et al., 2008; van Mon-
tfoort et al., 2008). One study compared granulosa cell (mainly mural
granulosa cell) gene expression proﬁles between follicles associated
with successful pregnancy and those associated with arrested
embryo development during IVF (Hamel et al., 2008). Identiﬁed can-
didates that positively correlate with oocyte development potential
include, but not limited to, genes associated with steroidogenesis
[hydroxy-delta-5-steroid dehydrogenase 3 beta- and steroid
delta-isomerase 1 (HSD3B1), ferredoxin 1 (FDX1) and cytochrome
P450 (CYP19A1)] and genes with potential involvement in apoptosis
[serpin peptidase inhibitor clade E member 2 (SERPINE2) and cell
division cycle 42 (CDC42)] (Hamel et al., 2008). Another study
attempted to identify differentially expressed genes between
cumulus cells derived from oocytes that develop to early cleavage
(EC) embryos and cumulus cells from oocytes that fail to develop
into EC (NEC) embryos (van Montfoort et al., 2008). The transcripts
of genes increased in NEC samples [glutathione peroxidase 3 (GPX3),
chemokine receptor 4 (CXCR4), stress-induced apoptosis inhibitor
(HSPB1), cyclin D2 (CCND2), 7-dehydrocholesterol reductase
(DHCR7), etc.] are reﬂective of a potentially hypoxic state of
the cumulus cell microenvironment or delayed maturation of the
oocytes (van Montfoort et al., 2008). Surprisingly, none of the
GDF9 target genes (HAS2, PTGS2, PTX3 and GREM1) identiﬁed by
other studies (McKenzie et al., 2004; Zhang et al., 2005) is overrepre-
sented in the EC samples (van Montfoort et al., 2008).
The aforementioned studies have generated valuable information on
granulosa cell gene expression proﬁling associated with oocyte com-
petence in animal models and humans. However, consistent markers
predictive of oocyte competence are lacking from these studies,
although HAS2 and GREM1 emerge in three different studies
(Table I). The inconsistency of molecular markers identiﬁed by
these studies may result from the lack of a common standard used
for embryo viability/competence (e.g. EC embryo versus conﬁrmed
pregnancy), differences in sampling (e.g. cumulus cells from individ-
ual COC versus pooled cumulus cells or mural granulosa cells) or dis-
tinct platforms utilized for genome-wide analyses. It should also be
noted that the diagnostic power will be substantially lessened if
embryos are grouped or multiple embryos are transferred in such
experiments. Therefore, more comprehensive studies which poten-
tially include SET to assess the pregnancy outcome are needed in a
clinical setting to establish/standardize objective molecular markers.
Oocyte-secreted factors: key local regulators
of oocyte competence?
Oocyte competence is profoundly affected by multiple endocrine,
paracrine and autocrine factors during oogenesis and follicular devel-
opment, the importance of which has been highlighted in culture
systems (Eppig et al., 1996; Eppig et al., 2000, 2002; Thomas et al.,
2003; Sirard et al., 2006). Herein, we focus on the perspective of
oocyte-secreted factors because of their unique roles in coordinating
folliculogenesis (Eppig, 2001; Matzuk et al., 2002) and the relative
paucity of knowledge on these factors. Oocyte-secreted factors,
especially GDF9 and BMP15, are principal regulators of follicular
development and fertility (Moore et al., 2004; Juengel and McNatty,
2005; McNatty et al., 2005). Gdf9 null mice are infertile with follicles
arrested at the one-layer primary follicle stage, indicating the essential
role of GDF9 in early folliculogenesis (Dong et al., 1996). In contrast,
targeted disruption of mouse Bmp15 results in subfertile animals with
minimal histopathological alterations in the ovary except the defective
cumulus phenotype (Yan et al., 2001). Recently, transgenic mice with
oocyte overexpression of BMP15 (a chimeric protein of human
BMP15 proregion–mouse BMP15 mature region) reveals the growth-
Table I. Granulosa cell markers potentially associated with oocyte competence.
Granulosa cell markers Subject Outcome/animal
model
Sampling Reference
Candidate gene experiment
bHAS2, PTGS2, GREM1 Human Day 3 embryo CCs from individual COC (McKenzie et al., 2004)
bHAS2, GREM1 Human Day 3 embryo CCs from individual COC (Cillo et al., 2007)
aSTAR, PTGS2, AREG, CX43, SCD1, SCD5 Human Blastocyst CCs from individual COC (Feuerstein et al., 2007)
Microarray experiment
bPTX3 Human Day 3 embryo Pooled CCs from COCs (array); CCs
from individual COC (PCR)
(Zhang et al., 2005)
bHSD3B1, FDX1, CYP19A1, SERPINE2, CDC42 Human Conﬁrmed pregnancy Mural GCs and CCs (pooled) (Hamel et al., 2008)
aGPX3, CXCR4, HSPB1, CCND2, DHCR7,
DVL3, TRIM28, CTNND1
Human Early cleavage CCs from individual COCs (van Montfoort et al., 2008)
bHAS2, TNFAIP6, PTGS2, GREM1, INHBA,
EGFR, BTC, CD44
Cattle IVM-blastocyst rate CCs from pooled COCs (Assidi et al., 2008)
aCTSB, CTSS, CTSZ Cattle Poor oocyte quality
model
CCs from pooled COCs (Bettegowda et al., 2008)
Expression of markers is negatively (a) or positively (b) associated with oocyte competence. Only conﬁrmed candidate genes are listed for the microarray
experiment. CCs, cumulus cells; GCs, granulosa cells; COC, cumulus oocyte complex.
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Our genetic studies clearly illustrate the interaction between BMP15
and GDF9 in the mouse ovary (Yan et al., 2001). Moreover, species-
speciﬁc roles of oocyte-secreted factors have also been demonstrated,
and it has been well documented that ewes carrying heterozygous
mutations of BMP15 or GDF9 have enhanced ovulation rates,
whereas ewes that are homozygous for BMP15 or GDF9 mutations
are infertile with defective follicular development (Galloway et al.,
2000; Montgomery et al., 2001; Hanrahan et al., 2004; McNatty
et al., 2005). Distinct and cooperative roles of BMP15 and GDF9 in
regulating ovulation rate in sheep were highlighted by the evidence
that carriers of single-copy mutations of both BMP15 and GDF9
have higher ovulation rates than those with single mutations of
either gene (Hanrahan et al., 2004). In corroborating the signiﬁcant
roles of these oocyte-secreted factors in follicular development and
ovarian function in humans, mutations of both BMP15 and GDF9
genes have been identiﬁed in patients with premature ovarian failure
(Di Pasquale et al., 2004; Dixit et al., 2006; Laissue et al., 2006) or,
more accurately, primary ovarian insufﬁciency (Welt, 2008), although
the association of BMP15 mutation with this disorder warrants further
investigation (Ledig et al., 2008).
In further support of the interaction between BMP15 and GDF9, a
recent study by Su et al. (2008) demonstrates the cooperativity of
BMP15 and GDF9 in regulating cumulus cell cholesterol biosynthesis.
However, little was known about the potentially complex interactions
of the oocyte-secreted factors except GDF9 and BMP15, until the
description of the cooperativity between BMP15 and another oocyte-
produced factor, ﬁbroblast growth factor 8B (FGF8B), in promoting
glycolysis (Sugiura et al., 2007). The above study revealed that
oocytes from Bmp15
2/2 mice and Gdf9
þ/2; Bmp15
2/2 double-
mutant mice are deﬁcient in promoting glycolysis and inducing gene
expressions of the glycolytic enzymes, platelet phosphofructokinase
(Pfkp) and lactate dehydrogenase A (Ldha). To further address the
role of GDF9 and BMP15, recombinant BMP15, GDF9 and FGF8B
proteins were tested in the cumulus cell cultures. Through examining
the various combinations of treatment, the authors demonstrated that
combinationof BMP15and FGF8Bis capable of promoting glycolysis
and gene expression of glycolytic enzymes (Sugiura et al., 2007).
Since mammalian oocytes are deﬁcient in the glycolysis pathway
and dependent on the glycolytic products from cumulus cells, the
BMP15 and FGF8B from the oocytes regulating this important func-
tion may be of particular signiﬁcance for oocyte development.
Although one major advantage of IVM versus traditional IVF is to
bypass the ovarian stimulation procedure that may cause ovarian
stimulation syndrome (Rao and Tan, 2005), IVM often produces low-
quality oocytes in contrast to in vivo matured oocytes (Dunning et al.,
2007). Since oocyte-secreted factors are of paramount importance in
regulating cumulus cell functions favorable to oocyte development,
an interesting question is raised: can oocyte-secreted factors be
applied to IVM to improve the microenvironment surrounding the
oocyte and thus enhance the quality of the oocyte and embryo devel-
opment (Hussein et al., 2006; Gilchrist and Thompson, 2007)?
Hussein et al. (2006) treated bovine COCs with BMP15 and/or
GDF9 and observed an increase in the oocyte developmental potential
to blastocyst stage. Furthermore, application of antagonists of BMP15
(follistatin) or GDF9 (ALK4/5/7 inhibitor; SB431542) can reduce the
oocyte developmental competence (Hussein et al., 2006). The same
group subsequently demonstrated that addition of GDF9 to the IVM
medium can promote mouse embryo development and increase fetal
viability without affecting embryo implantation rate (Yeo et al.,
2008). These data generate enthusiasm in the ﬁeld of assisted repro-
duction, although they are derived from animal models. In the
future, extensive research should be undertaken to evaluate the
effectiveness of combinations of oocyte-secreted factors in promoting
oocyte competence in both animal models and humans.
Summary
Recent studies on the intercellular communication between germ cells
and companion somatic cells reveal the potential of cumulus cell
markers as reliable molecular predictors of oocyte developmental
competence, as well as the oocyte-secreted factors as enhancers of
oocyte quality (Table I and Fig. 1). Prior to the establishment of stan-
dardized criteria for oocyte selection utilizing cumulus cell gene
markers as key parameters, well-controlled clinical studies are
needed to evaluate the potential of various reported cumulus gene can-
didates as predictors of oocyte quality. The veriﬁed candidates from
different functional categories may thus be included as markers for
oocyte competence. One major challenge faced to evaluate the effec-
tiveness of oocyte-secreted factors to improve oocyte competence in
human IVM stems from our limited knowledge of the identity and/
or cooperativity of these factors in the oocyte–somatic cell regulatory
loop. Given the potentially complex interaction among oocyte-
secreted factors (Su et al., 2004; Sugiura et al., 2007; Su et al.,
2008) and their divergence among species (Juengel and McNatty,
2005; Bettegowda et al., 2007), the question is: what combination
of the oocyte-produced factors may have the most potent synergistic
effect in the human IVM system? Moreover, the hurdle of lack of stan-
dardized preparations of the recombinant proteins (Pangas and
Matzuk, 2005) should be overcome before the clinical trials can be
implemented. With the availability of a reliable approach capable of
identifying the best quality oocytes/embryos, multiple embryo transfer
Figure 1: Potential intrafollicular predictors and regulators of oocyte quality
within the oocyte–somatic cell regulatory loop. Oocyte-secreted factors
(GDF9, BMP15, FGF8B and other unknown factors) can act on the adjacent
cumulus cells via SMAD2/3, SMAD1/5/8 or other pathways to induce the
expression of genes from a variety of categories (e.g. cumulus expansion-
related genes Has2 and Ptgs2). Some of the markers may be indirect and
reliable parameters to assess oocyte competence. The oocyte-produced
factors can regulate numerous cumulus cell functions such as cumulus expan-
sion, apoptosis, metabolism (glycolysis and cholesterol synthesis), and these
functions are critical in the development of oocyte competence. It is unclear
whether oocyte-secreted factors can signal through autocrine pathway to regu-
late oocyte function. GDF9, growth differentiation factor 9; BMP15, bone mor-
phogenetic protein 15; FGF8B, ﬁbroblast growth factor 8B; Has2, hyaluronan
synthase 2; Ptgs2, prostaglandin-endoperoxide synthase 2; Grem1, gremlin 1.
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delineating the nature of novel oocyte-secreted factors and decipher-
ing the interaction/cooperativity of these factors will be informative
and should shed new light on our understanding of the enigma of
oocyte maturation and developmental competence.
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